Samantha Jane Mills1,2, Calvin Soh2,
Gerard Thompson1, Giovanni Buonaccorsi1, Catherine
McBain3, Sha Zhao1, Geoff James Martin Parker1,
Alan Jackson1,2
1Imaging Science and Biomedical
Engineering, University of Manchester, Manchester, Greater Manchester, United
Kingdom; 2Department of Neuroradiology, Salford Royal Foundation
Trust Hospital, Salford, Greater Manchester, United Kingdom; 3Department
of Clinical Oncology, Christie Hospital, Manchester, Greater Manchester,
United Kingdom
This
study describes the relationship between the DCE-MRI derived measure, Enhancing
Fraction, and overall survival in patients with Glioblastoma Multiforme, with
the findings of increased survival in association with elevated Enhancing
Fraction.